TG Therapeutics Inc
NASDAQ:TGTX

Watchlist Manager
TG Therapeutics Inc Logo
TG Therapeutics Inc
NASDAQ:TGTX
Watchlist
Price: 31.35 USD -2.03% Market Closed
Market Cap: 5B USD

Wall Street
Price Targets

TGTX Price Targets Summary
TG Therapeutics Inc

Wall Street analysts forecast TGTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TGTX is 45.17 USD with a low forecast of 13.13 USD and a high forecast of 63 USD.

Lowest
Price Target
13.13 USD
58% Downside
Average
Price Target
45.17 USD
44% Upside
Highest
Price Target
63 USD
101% Upside
TG Therapeutics Inc Competitors:
Price Targets
4BB
4Basebio PLC
152% Upside
2696
Shanghai Henlius Biotech Inc
57% Upside
206650
EuBiologics Co Ltd
58% Upside
SCLP
Scancell Holdings PLC
219% Upside
IPH
Innate Pharma SA
206% Upside
TECX
AVROBIO Inc
312% Upside
QURE
Uniqure NV
192% Upside
MIRM
Mirum Pharmaceuticals Inc
38% Upside

Revenue
Forecast

Revenue Estimate
TG Therapeutics Inc

The compound annual growth rate of TG Therapeutics Inc's revenue for the next 4 years is 46%.

N/A
Past Growth
46%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
TG Therapeutics Inc

The compound annual growth rate of TG Therapeutics Inc's operating income for the next 4 years is 98%.

N/A
Past Growth
98%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
TG Therapeutics Inc

The compound annual growth rate of TG Therapeutics Inc's net income for the next 4 years is 111%.

N/A
Past Growth
111%
Estimated Growth
Estimates Accuracy
-47%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TGTX's stock price target?
Price Target
45.17 USD

According to Wall Street analysts, the average 1-year price target for TGTX is 45.17 USD with a low forecast of 13.13 USD and a high forecast of 63 USD.

What is TG Therapeutics Inc's Revenue forecast?
Projected CAGR
46%

The compound annual growth rate of TG Therapeutics Inc's revenue for the next 4 years is 46%.

What is TG Therapeutics Inc's Operating Income forecast?
Projected CAGR
98%

The compound annual growth rate of TG Therapeutics Inc's operating income for the next 4 years is 98%.

What is TG Therapeutics Inc's Net Income forecast?
Projected CAGR
111%

The compound annual growth rate of TG Therapeutics Inc's net income for the next 4 years is 111%.

Back to Top